Immediate Impact
2 by Nobel laureates 2 from Science/Nature 57 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Works of Mei Ji being referenced
The quest for nanoparticle-powered vaccines in cancer immunotherapy
2024
PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mei Ji | 472 | 229 | 257 | 66 | 1.2k | |
| Na Che | 419 | 167 | 930 | 57 | 1.5k | |
| Zhaoyuan Chen | 167 | 109 | 339 | 53 | 1.1k | |
| Zheng Cao | 361 | 256 | 455 | 81 | 1.2k | |
| Jianping Zuo | 151 | 71 | 696 | 48 | 1.6k | |
| Won Kyung Kim | 133 | 105 | 488 | 75 | 1.1k | |
| Zihan Zheng | 93 | 82 | 651 | 80 | 1.3k | |
| Zhirong Chen | 105 | 104 | 514 | 84 | 1.2k | |
| Qingmin Sun | 231 | 99 | 670 | 53 | 1.5k | |
| Mark J. Thompson | 75 | 65 | 631 | 60 | 1.7k | |
| Xiaoqiang Yue | 176 | 114 | 418 | 39 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...